Exchange: NASDAQ·Updated 07:52 PM EDT
EDIT logo

EDIT Editas Medicine Inc

$3.16
$0.14
(4.24%)
Today
Closed $3.16
$0.0193
(0.61%)
After Hours
Reported EarningsAug 5
Mkt Cap$485.31M
Vol3.27M

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA.
61

Bullish Sentiment

How do you feel about EDIT?

Advertisement|Remove ads.